US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AlphaTON Capital Corp.

0.1545

-0.0016-1.02%

Post-market: 0.15460.0001+0.06%19:59 EDT

Volume:2.75M

Turnover:416.95K

Market Cap:3.62M

PE:-0.04

High:0.1577

Open:0.1542

Low:0.1434

Close:0.1561

52wk High:13.80

52wk Low:0.1358

Shares:23.43M

Float Shares:19.72M

Volume Ratio:0.69

T/O Rate:13.93%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.1767

EPS(LYR):-5.7202

ROE:-1356.05%

ROA:-132.71%

PB:0.50

PE(LYR):-0.03

Loading ...

Overview Company News Filings

Company Profile

Company Name:

AlphaTON Capital Corp.

Exchange:

NASDAQ

Establishment Date:

- -

Employees:

2

Office Location:

Clarence Thomas Building,P.O. Box 4649,Road Town,Tortola,British Virgin Islands

Website:

http://www.alphacompute.ai

Zip Code:

- -

Phone:

- -

Fax:

- -

Introduction:

Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline includes PORT-2 for treatment of refractory NSCLC, melanoma, and refractory melanoma that is in phase I and phase II clinical trials; PORT-3, for treatment of solid tumors, which is in phase I clinical trials; PORT-6, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ia clinical trials; PORT-7, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ib clinical trials; PORT-1, an intratumoral amphiphilic solutions for treatment of advanced soft tissue sarcoma, which is in phase 3 clinical trials; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors that is in preclinical trials. The company is based in Tortola, British Virgin Islands.

Directors

Name

Position

Brittany Kaiser

Chief Executive Officer and Director

Enzo Villani

Chief Investment Officer and Director

Michael Huskins

Independent Director

F. Daniel Siciliano

Director

Michael Terpin

Director

Shareholders

Name

Position

Brittany Kaiser

Chief Executive Officer and Director

Liza Horowitz

Chief Operating Officer

Wes Levitt

Chief Financial Officer

Enzo Villani

Chief Investment Officer and Director

Yury Mitin

Chief Business Development Officer

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/ALP/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALP","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALP\",,,,,undefined,":{"symbol":"ALP","market":"US","secType":"STK","nameCN":"AlphaTON Capital Corp.","latestPrice":0.1545,"timestamp":1787342400000,"preClose":0.1561,"halted":0,"volume":2747546,"hourTrading":{"tag":"盘后","latestPrice":0.1546,"preClose":0.1545,"latestTime":"19:59 EDT","volume":138306,"amount":21193.490403,"timestamp":1787356795254,"change":0.0001,"changeRate":0.000647,"amplitude":0.016828},"delay":0,"changeRate":-0.010249839846252341,"floatShares":19720700,"shares":23434600,"eps":-4.176686,"marketStatus":"Not Yet Opened","change":-0.0016,"latestTime":"08-21 16:00:00 EDT","open":0.1542,"high":0.1577,"low":0.1434,"amount":416950.16151836,"amplitude":0.091608,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.176686,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":0.1561,"preHourTrading":{"tag":"盘前","latestPrice":0.1594,"preClose":0.1561,"latestTime":"09:27 EDT","volume":346508,"amount":54644.98382552,"timestamp":1787318844509,"change":0.0033,"changeRate":0.02114,"amplitude":0.089686},"postHourTrading":{"tag":"盘后","latestPrice":0.1546,"preClose":0.1545,"latestTime":"19:59 EDT","volume":138306,"amount":21193.490403,"timestamp":1787356795254,"change":0.0001,"changeRate":0.000647,"amplitude":0.016828},"volumeRatio":0.6891636837898361},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALP\",,,,,undefined,":{"symbol":"ALP","floatShares":19720700,"roa":"-132.71%","roe":"-1356.05%","lyrEps":-5.720202,"volumeRatio":0.6891636837898361,"shares":23434600,"dividePrice":0,"high":0.1577,"amplitude":0.091608,"preClose":0.1561,"low":0.1434,"week52Low":0.1358,"pbRate":"0.50","psRate":"37.33","week52High":13.8,"institutionHeld":0.2646,"latestPrice":0.1545,"eps":-4.176686,"divideRate":0,"volume":2747546,"delay":0,"ttmEps":-4.176686,"open":0.1542,"prevYearClose":0.6,"prevWeekClose":0.1734,"prevMonthClose":0.1963,"prevQuarterClose":0.254,"fiveDayClose":0.1734,"twentyDayClose":0.216,"sixtyDayClose":0.4461},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALP\",params:#limit:5,,,undefined,":[{"date":"2026-07-15","symbol":"ALP","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1784145600000,"name":null,"time":"Post-Mkt","dateTimestamp":1784088000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALP\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALP\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1787025600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALP\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALP","date":"2026-08-21","current":-0.036991,"percent":0.987952,"low":-0.710921,"twenty":-0.456796,"median":-0.385908,"eighty":-0.121541,"high":-0.091754,"avg":-0.346809,"sd":0.168129,"marketCap":3663803},"quantilePoints":[{"date":"2026-04-24","current":-0.287956,"twenty":-0.409118,"median":-0.361912,"eighty":-0.317538,"marketCap":4288529},{"date":"2026-05-01","current":-0.37214,"twenty":-0.378088,"median":-0.36026,"eighty":-0.346365,"marketCap":5542280},{"date":"2026-05-08","current":-0.409118,"twenty":-0.4066,"median":-0.377647,"eighty":-0.355964,"marketCap":6092992},{"date":"2026-05-15","current":-0.519265,"twenty":-0.423531,"median":-0.37985,"eighty":-0.35993,"marketCap":7733414},{"date":"2026-05-22","current":-0.606124,"twenty":-0.519265,"median":-0.402824,"eighty":-0.366003,"marketCap":9027003},{"date":"2026-05-29","current":-0.692039,"twenty":-0.571255,"median":-0.421549,"eighty":-0.372644,"marketCap":10306531},{"date":"2026-06-05","current":-0.431147,"twenty":-0.57267,"median":-0.431855,"eighty":-0.375161,"marketCap":6421077},{"date":"2026-06-12","current":-0.424853,"twenty":-0.571255,"median":-0.424853,"eighty":-0.377269,"marketCap":6327338},{"date":"2026-06-18","current":-0.408803,"twenty":-0.569618,"median":-0.424853,"eighty":-0.377647,"marketCap":6088305},{"date":"2026-06-26","current":-0.395113,"twenty":-0.548061,"median":-0.424853,"eighty":-0.379378,"marketCap":5884425},{"date":"2026-07-02","current":-0.406915,"twenty":-0.525024,"median":-0.422257,"eighty":-0.381518,"marketCap":6060184},{"date":"2026-07-10","current":-0.377647,"twenty":-0.519265,"median":-0.408803,"eighty":-0.378906,"marketCap":5624301},{"date":"2026-07-17","current":-0.123707,"twenty":-0.519265,"median":-0.408961,"eighty":-0.377647,"marketCap":4778312},{"date":"2026-07-24","current":-0.147536,"twenty":-0.505418,"median":-0.402824,"eighty":-0.374154,"marketCap":5698728},{"date":"2026-07-31","current":-0.120921,"twenty":-0.492609,"median":-0.396372,"eighty":-0.36059,"marketCap":4670704},{"date":"2026-08-07","current":-0.110713,"twenty":-0.470423,"median":-0.394956,"eighty":-0.231837,"marketCap":4276393},{"date":"2026-08-14","current":-0.103178,"twenty":-0.458558,"median":-0.391494,"eighty":-0.130534,"marketCap":3985354},{"date":"2026-08-21","current":-0.094853,"twenty":-0.456796,"median":-0.385908,"eighty":-0.121541,"marketCap":3663803}],"updateTime":1787541443446},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":233586353,"employeeNum":2,"address":"Clarence Thomas Building,P.O. Box 4649,Road Town,Tortola,British Virgin Islands","fiscalYearEnd":"03-31"},"stockCompanyDetail":{"websiteUrl":"http://www.alphacompute.ai","stockEarnings":[{"period":"1week","weight":-0.109},{"period":"1month","weight":-0.3642},{"period":"3month","weight":-0.5757},{"period":"6month","weight":-0.6282},{"period":"1year","weight":-0.9826},{"period":"ytd","weight":-0.7425}],"compareEarnings":[{"period":"1week","weight":-0.0137},{"period":"1month","weight":0.0245},{"period":"3month","weight":0.0269},{"period":"6month","weight":0.1107},{"period":"1year","weight":0.2048},{"period":"ytd","weight":0.1229}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Portage Biotech Inc., a clinical stage immune-oncology company, engages in the research and develops pharmaceutical and biotechnology products. Its product pipeline includes PORT-2 for treatment of refractory NSCLC, melanoma, and refractory melanoma that is in phase I and phase II clinical trials; PORT-3, for treatment of solid tumors, which is in phase I clinical trials; PORT-6, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ia clinical trials; PORT-7, an A2AR inhibitor to treat A2A & A2B high solid tumors that is in phase Ib clinical trials; PORT-1, an intratumoral amphiphilic solutions for treatment of advanced soft tissue sarcoma, which is in phase 3 clinical trials; PORT-4, a nanolipogel co-formulations to treat of solid tumors that is in preclinical trials; and PORT-5, a VLP-STING to treat of solid tumors that is in preclinical trials. The company is based in Tortola, British Virgin Islands.","yearOnYearQuotes":[{"month":1,"riseRate":0.2,"avgChangeRate":-0.1663},{"month":2,"riseRate":0.2,"avgChangeRate":-0.198741},{"month":3,"riseRate":0.166667,"avgChangeRate":0.038631},{"month":4,"riseRate":0.5,"avgChangeRate":-0.099309},{"month":5,"riseRate":0.666667,"avgChangeRate":0.347321},{"month":6,"riseRate":0.166667,"avgChangeRate":-0.291989},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.037346},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.02116},{"month":9,"riseRate":0.4,"avgChangeRate":0.075522},{"month":10,"riseRate":0.2,"avgChangeRate":-0.056477},{"month":11,"riseRate":0,"avgChangeRate":-0.320667},{"month":12,"riseRate":0.4,"avgChangeRate":-0.090161}],"exchange":"NASDAQ","name":"AlphaTON Capital Corp.","nameEN":"AlphaTON Capital Corp."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ALP\",market:\"US\",,,undefined,":{"directors":[{"name":"Brittany Kaiser","position":"Chief Executive Officer and Director"},{"name":"Enzo Villani","position":"Chief Investment Officer and Director"},{"name":"Michael Huskins","position":"Independent Director"},{"name":"F. Daniel Siciliano","position":"Director"},{"name":"Michael Terpin","position":"Director"}],"executives":[{"name":"Brittany Kaiser","position":"Chief Executive Officer and Director"},{"name":"Liza Horowitz","position":"Chief Operating Officer"},{"name":"Wes Levitt","position":"Chief Financial Officer"},{"name":"Enzo Villani","position":"Chief Investment Officer and Director"},{"name":"Yury Mitin","position":"Chief Business Development Officer"}]}}}